Advertisement
Advertisement
SNSE
Sensei Biotherapeutics, Inc. Common Stock
0.47459
USD-0.02
-4.13%
Feb 21, 15:58 UTC -5
Closed
After-Market
0.475
0
+0.08%
Sensei Biotherapeutics, Inc. Common Stock Profile
About
Info & Links
CEO
John Celebi
Headquarters
ROCKVILLE, MD 20850, UNITED STATES
Industry
Sector
Website
Auditor
Deloitte & Touche LLP
Share holders
208
Employees
27
Sensei Biotherapeutics, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
11.95M
Enterprise Value
-6.15M
Enterprise Value/EBITDA(ttm)
0.20
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
0.26
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
0.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
0.00%
Return on Equity(ttm)
-53.86%
Return on Invested Capital(ttm)
-54.18%
Return on Assets(ttm)
-46.91%
Income Statement
Revenue(ttm)
0.00
Revenue Per Share(ttm)
0.00
Gross Profit(ttm)
0.00
EBITDA(ttm)3
-31.16M
Net Income Available to Common(ttm)
-29.80M
Diluted EPS(ttm)
-1.19
Share Statistics
Beta (5Y Monthly)
0.17
52-Week Change
-36.72%
S&P 500 52-Week Change
18.16%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
25.15M
Dividend Yield
0.00%
Float4
19.62M
% Held by Insiders
22.00%
% Held by Institutions
10.50%
Balance Sheet
Total Cash(mrq)
47.00M
Total Cash Per Share(mrq)
1.87
Total Debt(mrq)
1.04M
Total Debt/Equity(mrq)
2.27%
Current Ratio(mrq)
8.84%
Quick Ratio(mrq)
8.84%
Book Value Per Share(mrq)
1.82
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.75
Free Cash Flow(ytd)
-19.02M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement